125 related articles for article (PubMed ID: 34565017)
1. Targeted massively parallel sequencing in the management of cytogenetically normal lymphoid malignancies.
Ikbal Atli E; Gurkan H; Atli E; Yalcintepe S; Demir S; Eker D; Kalkan R; Muzaffer Demir A
J BUON; 2021; 26(4):1540-1548. PubMed ID: 34565017
[TBL] [Abstract][Full Text] [Related]
2. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
3. Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies.
Artymiuk CJ; Basu S; Koganti T; Tandale P; Balan J; Dina MA; Barr Fritcher EG; Wu X; Ashworth T; He R; Viswanatha DS
J Mol Diagn; 2024 Jul; 26(7):583-598. PubMed ID: 38582399
[TBL] [Abstract][Full Text] [Related]
4. Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.
Pillonel V; Juskevicius D; Bihl M; Stenner F; Halter JP; Dirnhofer S; Tzankov A
Leuk Lymphoma; 2020 Nov; 61(11):2568-2583. PubMed ID: 32623938
[TBL] [Abstract][Full Text] [Related]
5. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
6. Genome sequencing of lymphoid malignancies.
Mullighan CG
Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
[TBL] [Abstract][Full Text] [Related]
7. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
[TBL] [Abstract][Full Text] [Related]
9. The Importance of Targeted Next-Generation Sequencing Usage in Cytogenetically Normal Myeloid Malignancies.
Atli EI; Gurkan H; Atli E; Kirkizlar HO; Yalcintepe S; Demir S; Demirci U; Eker D; Mail C; Kalkan R; Demir AM
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021013. PubMed ID: 33489052
[TBL] [Abstract][Full Text] [Related]
10. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation.
Bacquet J; Stojkovic T; Boyer A; Martini N; Audic F; Chabrol B; Salort-Campana E; Delmont E; Desvignes JP; Verschueren A; Attarian S; Chaussenot A; Delague V; Levy N; Bonello-Palot N
BMJ Open; 2018 Oct; 8(10):e021632. PubMed ID: 30373780
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Yasuda T; Sanada M; Nishijima D; Kanamori T; Iijima Y; Hattori H; Saito A; Miyoshi H; Ishikawa Y; Asou N; Usuki K; Hirabayashi S; Kato M; Ri M; Handa H; Ishida T; Shibayama H; Abe M; Iriyama C; Karube K; Nishikori M; Ohshima K; Kataoka K; Yoshida K; Shiraishi Y; Goto H; Adachi S; Kobayashi R; Kiyoi H; Miyazaki Y; Ogawa S; Kurahashi H; Yokoyama H; Manabe A; Iida S; Tomita A; Horibe K
Cancer Sci; 2020 Sep; 111(9):3367-3378. PubMed ID: 32619037
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
14. The role of molecular biology in the diagnosis of lymphoid neoplasms.
Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
[TBL] [Abstract][Full Text] [Related]
15. Integrative systems medicine approaches to identify molecular targets in lymphoid malignancies.
Frazzi R; Auffray C; Ferrari A; Filippini P; Rutella S; Cesario A
J Transl Med; 2016 Sep; 14(1):252. PubMed ID: 27580852
[TBL] [Abstract][Full Text] [Related]
16. Impact on Clinical Decision Making of Next-Generation Sequencing in Pediatric Epilepsy in a Tertiary Epilepsy Referral Center.
Hoelz H; Herdl C; Gerstl L; Tacke M; Vill K; von Stuelpnagel C; Rost I; Hoertnagel K; Abicht A; Hollizeck S; Larsen LHG; Borggraefe I
Clin EEG Neurosci; 2020 Jan; 51(1):61-69. PubMed ID: 31554424
[No Abstract] [Full Text] [Related]
17. Clinical application of a phenotype-based NGS panel for differential diagnosis of inherited kidney disease and beyond.
Oh J; Shin JI; Lee K; Lee C; Ko Y; Lee JS
Clin Genet; 2021 Feb; 99(2):236-249. PubMed ID: 33095447
[TBL] [Abstract][Full Text] [Related]
18. Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.
Arunachalam AK; Maddali M; Aboobacker FN; Korula A; George B; Mathews V; Edison ES
J Clin Immunol; 2021 Feb; 41(2):393-413. PubMed ID: 33225392
[TBL] [Abstract][Full Text] [Related]
19. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
20. ClonoSEQ assay for the detection of lymphoid malignancies.
Monter A; Nomdedéu JF
Expert Rev Mol Diagn; 2019 Jul; 19(7):571-578. PubMed ID: 31179776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
